Related Experiment Videos
Correlation between serotonin uptake and imipramine binding in schizophrenic patients
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1982
Summary
Platelet serotonin uptake is significantly lower in schizophrenia patients compared to healthy individuals. This reduced serotonin transporter function correlates with imipramine binding in these patients.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a complex psychiatric disorder with suspected neurochemical underpinnings.
- Platelets offer a model system for studying neurotransmitter transporter function in vivo.
Purpose of the Study:
- To investigate serotonin transporter (SERT) activity in schizophrenia.
- To compare SERT function and imipramine binding in patients with schizophrenia and healthy controls.
Main Methods:
- Assessed active serotonin uptake by platelets.
- Measured imipramine binding to platelet membranes.
- Correlated serotonin uptake kinetics (Vmax) with imipramine binding affinity.
Main Results:
- Serotonin uptake by platelets was significantly reduced in patients with schizophrenia compared to healthy controls.
- A significant positive correlation was found between the maximum velocity (Vmax) of serotonin uptake and imipramine binding.
- Imipramine binding, a marker for SERT, reflects functional transporter capacity.
Conclusions:
- Platelet serotonin transporter function is impaired in schizophrenia.
- The Vmax of serotonin uptake is a reliable indicator of SERT availability and function in this patient group.